Wasatch Advisors’s LeMaitre Vascular LMAT Stock Holding History

Wasatch Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-231,875	Closed	-$8.34M	–	249
2019 Q4	$8.34M	Sell	231,875 -90	-0%	-$3.11K	0.07%	164
2019 Q3	$7.93M	Buy	231,965 +13,266	+6%	+$424K	0.08%	154
2019 Q2	$6.12M	Sell	218,699 -85	-0%	-$2.36K	0.06%	163
2019 Q1	$6.78M	Buy	218,784 +76,921	+54%	+$2.05M	0.07%	145
2018 Q4	$3.35M	Sell	141,863 -9,672	-6%	-$264K	0.04%	188
2018 Q3	$5.87M	Buy	151,535 +30,163	+25%	+$1.09M	0.07%	158
2018 Q2	$4.06M	Buy	121,372 +17,505	+17%	+$623K	0.05%	174
2018 Q1	$3.76M	Buy	+103,867	New	+$3.6M	0.05%	173

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wasatch Advisors's LMAT Position: Q1 2020 in Review

Wasatch Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 231,875 shares — an estimated $8.34M sold.

Wasatch Advisors first reported a position in LMAT in Q1 2018 and held it in 8 quarters. The position peaked at $8.34M in Q4 2019. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

Wasatch Advisors reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
Wasatch Advisors sold 231,875 LeMaitre Vascular shares in Q1 2020, an estimated $8.34M.
Wasatch Advisors first reported a position in LeMaitre Vascular in Q1 2018 and held it in 8 quarters.
Wasatch Advisors's LeMaitre Vascular position peaked at $8.34M in Q4 2019.
144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Wasatch Advisors's 13F filing for Q1 2020, filed 8 May 2020.